Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Infarction; Myocardial Infarction; Ventricular Dysfunction; Ventricular Dysfunction, Left Phase 1 ClinicalTrials
Fibrosis; Liver Cirrhosis Phase 2 ClinicalTrials
Diabetes Mellitus, Type 2 Phase 1 ClinicalTrials
Spinal Cord Injuries; Wounds and Injuries Phase 2 ClinicalTrials
Diabetes Mellitus; Peripheral Arterial Disease; Peripheral Vascular Diseases Phase 1/Phase 2 ClinicalTrials
Diabetic Foot; Ischemia Phase 1/Phase 2 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 1 Phase 1/Phase 2 ClinicalTrials
Cardiomyopathies; Cardiomyopathy, Dilated Phase 1/Phase 2 ClinicalTrials
Spinal Cord Injuries; Wounds and Injuries Phase 1/Phase 2 ClinicalTrials
Cardiomyopathies; Infarction; Ischemia; Myocardial Infarction Phase 1/Phase 2 ClinicalTrials
Muscular Dystrophies; Muscular Dystrophy, Duchenne Phase 1 ClinicalTrials
Drug-Related Side Effects and Adverse Reactions; Psoriasis Phase 1/Phase 2 ClinicalTrials
Osteoarthritis Phase 1/Phase 2 ClinicalTrials
Autistic Disorder Phase 1/Phase 2 ClinicalTrials
Fibrosis; Liver Cirrhosis Phase 1/Phase 2 ClinicalTrials
Diabetic Foot; Ischemia; Peripheral Arterial Disease; Peripheral Vascular Diseases; Vascular Diseases Phase 1 ClinicalTrials
Spinal Cord Injuries; Wounds and Injuries Phase 2 ClinicalTrials
Multiple Sclerosis; Sclerosis Phase 1/Phase 2 ClinicalTrials
Osteoarthritis; Osteoarthritis, Knee Phase 1 ClinicalTrials
Spinal Cord Injuries; Wounds and Injuries Phase 2 ClinicalTrials
Colitis; Colitis, Ulcerative; Ulcer Phase 1/Phase 2 ClinicalTrials
Arthritis; Arthritis, Rheumatoid Phase 1/Phase 2 ClinicalTrials
CONTENTS